Filing Flows › Comparisons › TEVA vs VTRS
Teva Pharmaceutical Industries vs Viatris: TEVA and VTRS compared
Teva Pharmaceutical Industries is the larger company: $4.4B of revenue in its latest quarter (Q3 2026) against $3.7B for Viatris (Q3 2026). Viatris is growing faster (-0.3% against -2% a year earlier). Teva Pharmaceutical Industries is more profitable, with an operating margin of 16.2% against 7.0%.
Where the money goes: TEVA and VTRS
Teva Pharmaceutical Industries (TEVA) · Q3 2026
Teva Pharmaceutical Industries, Q3 2026: revenue $4.4B (-2% year over year), operating margin 16.2%, net earnings $234M, operating cash flow $241M. The chart follows the revenue to costs, profit and cash.
Viatris (VTRS) · Q3 2026
Viatris, Q3 2026: revenue $3.7B (-0.3% year over year), operating margin 7.0%, net loss $325M, operating cash flow $899M. The chart follows the revenue to costs, profit and cash.
| Teva Pharmaceutical Industries (TEVA) | Viatris (VTRS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $4.4B | $3.7B |
| Revenue growth, Y/Y | -2% | -0.3% |
| Gross margin | 55.5% | — |
| Operating margin | 16.2% | 7.0% |
| Net earnings | $234M | −$325M |
| Net margin | 5.3% | -8.7% |
| Operating cash flow | $241M | $899M |
| Free cash flow | $121M | $814M |
| Market value | $49.4B | $22.1B |
| P/E | 95.0× | — |
| Analysts’ mean target | $49.08 | $21.00 |
Where the revenue comes from
Teva Pharmaceutical Industries
- Sale of goods: $3.7B (85%)
- Distribution: $421M (10%)
- Other: $184M (4%)
- Licensing arrangements: $49.0M (1%)
Viatris
- Brands: $2.5B (66%)
- Lipitor: $452M (12%)
- EpiPen® Auto-Injectors: $156M (4%)
- Lyrica ®: $114M (3%)
Questions
Which is bigger, Teva Pharmaceutical Industries or Viatris?
Teva Pharmaceutical Industries is the larger company: $4.4B of revenue in its latest quarter (Q3 2026) against $3.7B for Viatris (Q3 2026).
Is Teva Pharmaceutical Industries or Viatris growing faster?
Viatris is growing faster (-0.3% against -2% a year earlier).
Which is more profitable, Teva Pharmaceutical Industries or Viatris?
Teva Pharmaceutical Industries is more profitable, with an operating margin of 16.2% against 7.0%.
More: Teva Pharmaceutical Industries earnings · how Teva Pharmaceutical Industries makes money · Viatris earnings · how Viatris makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.